$2.15
-0.05-2.27%
At close: Aug 25, 5:00 PM EST
$2.16
-0.04-1.82%
Pre-Market: 4:00 AM EST
Grace Therapeutics Inc (GRCE) Stock Price, Quote, News & History
GRCENASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Grace Therapeutics (GRCE) stock?
You can purchase shares of Grace Therapeutics (NASDAQ:GRCE) through any online brokerage.
Who are Grace Therapeutics (GRCE) competitors?
Other companies in Grace Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
What is the forecast, or price target, for Grace Therapeutics (GRCE) stock?
Grace Therapeutics has a consensus price target of $10.00.
What is the current price for Grace Therapeutics (GRCE)?
The stock price for Grace Therapeutics (NASDAQ: GRCE) is $2.16 last updated August 26, 2026 at 5:58 PM EDT.
Does Grace Therapeutics (GRCE) pay a dividend?
There are no upcoming dividends for Grace Therapeutics.
When is Grace Therapeutics (NASDAQ:GRCE) reporting earnings?
Grace Therapeutics does not have any upcoming earnings scheduled.
Is Grace Therapeutics (GRCE) going to split?
There is no upcoming split for Grace Therapeutics.
What sector and industry does Grace Therapeutics (GRCE) operate in?
Grace Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
